NFCA Webinars are geared for those with celiac disease and other gluten-related disorders as well as the dietitians and providers who serve them. Thanks to the support of sponsors, these Webinars continue to be free of charge!
If you have a Webinar idea or topic you'd like to see discussed, please contact email@example.com.
Note: A recording of each Webinar will be posted along with the Webinar slides within 72 hours after the live Webinar ends. To download recorded Webinars and slides, visit the Archived Webinars page.
Accelerating Celiac Disease Research: With You, We Can Go Further
Tuesday, October 27, 2015 from 1 p.m. to 2 p.m. EST/10 a.m. to 11 a.m. PST
Join the National Foundation for Celiac Awareness for a special webinar to talk about the critical role patients play in research with three key leaders who are working to change the face of celiac disease:
- Jacob Hughey, PhD, Postdoctoral Fellow, Institute for Computational Health Sciences, University of California, San Francisco and diagnosed with celiac disease in 2012
- Francisco Leon, MD, PhD, Co-Founder, Chief Executive Officer and Chief Medical Officer, Celimmune
- Joseph A. Murray, MD, Mayo Clinic College of Medicine and NFCA Scientific/Medical Advisory Council member
Drs. Hughey, Leon and Murray will share examples of how patients have contributed to successful celiac disease research in the past and discuss how a motivated and educated patient community can continue to help to advance the field. Tune in to learn how patients, researchers and NFCA can work together to make a change.
About the Panelists
Jake Hughey, Postdoctoral Fellow at the Institute for Computational Health Sciences at the University of California
Jake Hughey is a postdoctoral fellow in the Institute for Computational Health Sciences at the University of California, San Francisco. He earned his PhD in Bioengineering from Stanford University. The goal of his research is to use math and computers to improve our understanding of biology and human health. Almost three years ago, he was diagnosed with celiac disease. After recovering from the disappointment of no longer being able to drink Hefeweizen, he realized he could apply his own research to study celiac disease. One of his current projects involves detecting patients with undiagnosed celiac disease using electronic medical records.
Francisco Leon, MD, PhD, Co-Founder and CEO/CMO of Celimmune
Francisco Leon, MD, PhD, is the co-founder and CEO/CMO of Celimmune, a clinical-stage biopharmaceutical company developing medicines for people with celiac disease. Francisco has over 20 years of experience in translational immunology in academia (NIAID/NIH), biotech (Alba Therapeutics, MedImmune) and Pharma (Bristol-Myers Squibb, Centocor/Janssen/Johnson & Johnson). Francisco is a clinical immunologist by training who received his MD and PhD from Autónoma University in Madrid, Spain. Francisco is also Adjunct Research Associate Professor of Medicine at Jefferson Medical College (Philadelphia) and has authored or co-authored more than 75 peer-reviewed articles and book chapters as well as several patents.
Joseph A. Murray, MD, Division of Gastroenterology at Mayo Clinic and Member of NFCA's Scientific/Medical Advisory Council
Dr. Murray studied medicine at National University of Ireland and internal medicine/gastroenterology training at Trinity College and Beaumont Hospital (Dublin) and the University of Iowa. He was on the faculty of the University of Iowa (1990-1998) before joining the Division of Gastroenterology at Mayo Clinic in Rochester, MN in 1998, becoming Professor of Medicine in 2004. Dr. Murray has a strong background/experience in basic/clinical gastroenterology, and his work spans basic/translational research in celiac disease focusing on immunology, genetics of the disease and immune responses to food and microbiota. He is the author/co-author of more than 235 scientific publications and 33 chapters, and his work is funded by the NIH, private foundations and commercial entities. He is past president of North American Society for the Study of Celiac Disease, and he serves on advisory boards for lay support groups and consults with several companies on the topic of celiac disease.View Webinar System Requirements